Skip to main content
. 2022 Dec 13;14(12):2790. doi: 10.3390/pharmaceutics14122790

Figure 4.

Figure 4

(a) The Zr-MOF/AMC/MTX nanocarrier and (b) its MTX release. Cell viability of (c) Zr-MOF/AMC and (d) Zr-MOF/AMC/MTX in L-02 and HepG2 cells. Reproduced with permission from Ref. [74], copyright (2020) Royal Society of Chemistry.